Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Operating Expenses: 2016-2024

Historic Other Operating Expenses for Collegium Pharmaceutical (COLL) over the last 6 years, with Dec 2024 value amounting to -$15.8 million.

  • Collegium Pharmaceutical's Other Operating Expenses fell 302.67% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.9 million, marking a year-over-year increase of 60.13%. This contributed to the annual value of -$15.8 million for FY2024, which is 84.83% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Other Operating Expenses of -$15.8 million as of FY2024, which was up 84.83% from -$104.1 million recorded in FY2023.
  • Collegium Pharmaceutical's Other Operating Expenses' 5-year high stood at $15.0 million during FY2021, with a 5-year trough of -$104.1 million in FY2023.
  • Its 3-year average for Other Operating Expenses is -$37.1 million, with a median of -$15.8 million in 2024.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Other Operating Expenses slumped by 1,300.59% in 2023, and later soared by 84.83% in 2024.
  • Yearly analysis of 4 years shows Collegium Pharmaceutical's Other Operating Expenses stood at $15.0 million in 2021, then crashed by 42.23% to $8.7 million in 2022, then tumbled by 1,300.59% to -$104.1 million in 2023, then soared by 84.83% to -$15.8 million in 2024.